HCPCS Level IIprocedureActive
G0138
Iv cipaglucosidase alfa-atga
BETOS: M1B
Effective: 2024-04-01
Description
Intravenous infusion of cipaglucosidase alfa-atga, including provider/supplier acquisition and clinical supervision of oral administration of miglustat in preparation of receipt of cipaglucosidase alfa-atga
Medicare Fee Schedule
2026 Medicare Physician Fee Schedule national payment rates
$0.00
Non-Facility Price
$0.00
Facility Price
0.21
Work RVU
5.88
Total RVU (Non-Fac)
XXX
Global Days